Member Info for BigDave13

On my watchlist. Any thoughts on potential sector/target/timeline?

The drug itself has been around for years. If you look at the Certificates, they are dated Jan 2020 & it also states Caution: Not fully tested. For research purposes only.
Nothing to see here.

A few thoughts in response to a couple of issues raised last evening.

From the SGS website “The trial, named ARCADIA, will commence with Professor Evans and the Excalibur team having sourced investment from Mubadala of Abu Dhabi, one of the world’s leading sovereign wealth funds, Excalibur itself and several high net worth individuals. This is in addition to funding secured from the UK Government through the UKRI / Innovate UK programme.”

In much the same way that Vela has invested with SGS to acquire an economic interest in the Asset, it appears that the same arrangement has been agreed with EML and other investors, although we do not know specific amounts or % returns. The relationship with EML does appear to be more than just as an investor though as they are now taking a more prominent role with managing the newsflow and the commercialisation aspects as well.

The Oct RNS states that SGS has acquired the right to develop and commercialise the Asset. I see this as a Licence Agreement with AZ retaining the IP. This may explain why the deal states that Vela receives 8% of proceeds “in excess of £19.2 million and after deduction of sums payable to the major pharmaceutical company”.

We now move forward 8 months to the Angelfish/Igraine RNS dated 11 June which states “EML has secured exclusive rights to and owns the patents on a drug, AZD1656”. Maybe a little simplistic but I just see this as a different use of the term rights. In this context, AZ has transferred the Patents over to EML but I would think that SGS has retained the rights to use the Asset as per the original Licence Agreement (assume novated over to EML).

Why did EML acquire the patents and what did they know at the time or was it just a speculative punt? How does this now impact the payment to the major pharmaceutical company? We probably won’t know the full details or even need to but no matter, just hoping for great results Mon week and a corresponding mega deal that makes this long wait worth it for us LTHs (and the world of course).

My source says your source speaketh b0ll0x!

Welcome newbie Muck165. They are good questions you have raised. I take it that SGS002 is an internal St George Street reference for AZD1656 but have seen no direct confirmation on this. The next point regarding rights is an interesting one which I have considered before but haven't yet formed a complete answer to. I will put together a few thoughts on this subject tomorrow.

I found this interesting although doesn't appear to reflect latest routes.
https://www.flightconnections.com/route-map-blue-air-0b

A bit crude but Wizz Air MC equates to around £42m per plane. Blue Air has 16 planes and it is reported that they intend to increase to 50 by 2025, so what value can be attributed here? Do the math.

When Sir Chris calls, big pharma listen & will be interested, it is not his first rodeo!. Not guaranteed, but would not surprise me if deal announced same day.

If all 01 Sept warrants exercised, that would take cash to say £2.4m. If results/deal confirmed, SP ticks up and all remaining warrants exercised, cash goes to say £4.75m & that is before including any proceeds from SGS deal. Wow!!

Yes that is true, volume soaking them up now. Where is warrants RNS? Hopefully JN is working on next deal/s to be revealed shortly alongside new BoD appt.

More money for Vela is good but dilutive for existing shareholders. Don't think it will impact SP leading into results day but maybe in longer term. Enough Warrants (& Options) to leave Vela with > 18bn shares.

TM, there are closer to 2bn warrants valued at £1.2m available to be exercised by 01 Sept. I summarised all warrants outstanding a few days ago, pls check my profile for relevant post.

There seems to be 2 trains of thought here, Warrant holders selling existing shares to de-risk prior to exercising warrants and/or forward selling those warrants. Either way, there should be an RNS to confirm number of warrants exercised I would have thought. Maybe tomorrow.

0.95p. Buckle up, rest of week leading into Bank Holiday is going to be exciting.

25-Aug-21 16:33:00 0.087 75,000,000 Unknown* 0.085 0.095 65.00k O
25-Aug-21 16:10:49 0.095 28,415,800 Unknown* 0.085 0.095 27.00k

ABDX is an interesting case study.

After 100% increase yesterday, it motored up another 40% or so mid morning to 85p. Dipped to 70p, back to 81p only to finish the day flat at 61p.

I'm sure there is a lesson there for all of us come Mon week. Will need to have conviction to sell into a rising SP to de-risk/profit take.

It has been a long time coming but nearly there. Twitter pump seems to have slowed a little. Just need to keep slowly building on this higher SP range moving into back end of next week. Thought warrants RNS may have been issued by now, must be inbound soon. Watching ABDX SP for inspiration and dreaming of what may be & they don't even have JN or Sir Chris on board.

ABDX closed Fri 30.5p, now 73p Ask & still rising into Day 2 post newsflow. Our turn soon.

Abingdon Health +109% today on news of COVID-19 IgG Antibody Self Test. The market like a Covid good news story.

OK, link didn't work. Just google:-
Two Shields Investee WeShop

Interesting, I found this interview re WeShop. A couple of years old, provides a brief outline of business from 1min to 11 mins. Indicates business is up and running back then in Beta but I am just not sure of current status. Here is website link, anyone want to subscribe and report back? Also Instagram and Twitter account links there.

https://www.**********.co.uk/media/5ddd1f5a052336001724ec53/?context=/articles/two-shields-investee-weshop-and-alan-green-on-4-stocks-6811c0b/

https://we.shop/

THGambler

Vela holds 71,429 shares at a cost of £100k. In Sept 2019, it reported that the investment had a paper value of £427k based on a recent funding round. In December of that year, it was reported that Vela was interested in disposing of the shares at minimum price of 550p each (value ~£385k). Primorus Investments (PRIM) acquired their shares in WeShop at prices of £536p & £586p. There has since been further rounds of funding so I would expect some dilution to these values.

Another investor is Brand Shields Systems (BRDS) and its CEO has been appointed to the Board of WeShop. In its latest accounts it states that WeShop has patiently developed its own proprietary and globally scalable e-commerce platform and established links with key partners to be able to offer its users an unparalleled selection of products within a personalised, highly interactive and rewarding social commerce model. Whatever that means! However, after >£10m funding I can’t find anything of substance on their development except for a simple homepage.

It goes on to say that BRDS understands that WeShop’s plans for an IPO continue to progress encouragingly. It then goes on to state that it carries the investment at cost in its book. This seems like a reasonable approach so let’s give Vela’s investment a value of £100k for now with a potential upside value to around £350k if further details on the business/ipo are published.

PS Did you know Leo Mansell (son of Nigel) is a Director and Dad is a shareholder.

HM, I estimate £35k/month based on last half year report although higher for that period which included the restructure. New Board appt due as well, so maybe that will push up cost a little. Full Year accounts due end of Sept so should provide further clarification.